Objectives: Oral lichen planus (OLP) is a chronic, immunologically mediated, mucocutaneous disorder. A wide range of topical and systemic therapies have been used in the treatment of OLP. The efficacy of IMOD (an Iran...Objectives: Oral lichen planus (OLP) is a chronic, immunologically mediated, mucocutaneous disorder. A wide range of topical and systemic therapies have been used in the treatment of OLP. The efficacy of IMOD (an Iranian new immunomodulator drug, con- taining selenium, carotene, and flavonoids) in the management of oral lichen planus was evaluated. Study design: In a before-after clinical trial study, thirty patients (21 women and 9 men;age range 35 - 66 years with 112 lesions) with lichen planus were enrolled. The study covered a three-month period of therapy by IMOD (400 mg/day) and a three-month follow-up period after drug cessation. Outcome mea- sures include soreness relief based on the “nu-meric scale”, and clinical improvement of lesion size and score. Saliva levels of TNF-α was analysed at the baseline and after treatment by ELISA. Statistical analysis of Wilcoxon and paired student’s t-test were used. Results: Approximately 85% of patients showed partial to complete improvement and re-mained sym- ptom free after drug cessation. There was no signifi-cant difference in mean saliva TNF-α level before and after the treatment. Conclusion: These results suggest that IMOD seems to be an effective alternative treat- ment for OLP and TNF-α may not be a good indica- tor for monitoring therapeutic response of OLP.展开更多
目的:探究临床药师参与下肢蜂窝组织炎患者伴感染性多器官功能障碍综合征(infectious multiple organ dysfunction syndrome,IMODS)的临床用药及其药学监护。方法:临床药师参与1例下肢蜂窝织炎伴感染性多器官功能障碍综合征患者的会诊,...目的:探究临床药师参与下肢蜂窝组织炎患者伴感染性多器官功能障碍综合征(infectious multiple organ dysfunction syndrome,IMODS)的临床用药及其药学监护。方法:临床药师参与1例下肢蜂窝织炎伴感染性多器官功能障碍综合征患者的会诊,并结合患者生理、病理情况、病原菌的培养及抗菌药物的作用特点,提出个体化抗感染治疗方案并实施药学监护。结果:临床医生采纳抗感染治疗方案后,停用头孢替安,改用利奈唑胺,以及加用氟康唑抗真菌感染治疗,症状得以控制,治疗效果较为确切。结论:临床药师参与抗感染用药会诊对促进患者病情改善和抗菌药物合理使用发挥了积极的作用。展开更多
文摘Objectives: Oral lichen planus (OLP) is a chronic, immunologically mediated, mucocutaneous disorder. A wide range of topical and systemic therapies have been used in the treatment of OLP. The efficacy of IMOD (an Iranian new immunomodulator drug, con- taining selenium, carotene, and flavonoids) in the management of oral lichen planus was evaluated. Study design: In a before-after clinical trial study, thirty patients (21 women and 9 men;age range 35 - 66 years with 112 lesions) with lichen planus were enrolled. The study covered a three-month period of therapy by IMOD (400 mg/day) and a three-month follow-up period after drug cessation. Outcome mea- sures include soreness relief based on the “nu-meric scale”, and clinical improvement of lesion size and score. Saliva levels of TNF-α was analysed at the baseline and after treatment by ELISA. Statistical analysis of Wilcoxon and paired student’s t-test were used. Results: Approximately 85% of patients showed partial to complete improvement and re-mained sym- ptom free after drug cessation. There was no signifi-cant difference in mean saliva TNF-α level before and after the treatment. Conclusion: These results suggest that IMOD seems to be an effective alternative treat- ment for OLP and TNF-α may not be a good indica- tor for monitoring therapeutic response of OLP.
文摘目的:探究临床药师参与下肢蜂窝组织炎患者伴感染性多器官功能障碍综合征(infectious multiple organ dysfunction syndrome,IMODS)的临床用药及其药学监护。方法:临床药师参与1例下肢蜂窝织炎伴感染性多器官功能障碍综合征患者的会诊,并结合患者生理、病理情况、病原菌的培养及抗菌药物的作用特点,提出个体化抗感染治疗方案并实施药学监护。结果:临床医生采纳抗感染治疗方案后,停用头孢替安,改用利奈唑胺,以及加用氟康唑抗真菌感染治疗,症状得以控制,治疗效果较为确切。结论:临床药师参与抗感染用药会诊对促进患者病情改善和抗菌药物合理使用发挥了积极的作用。
